A Phase 3, Randomized, Double-Blinded Study of IMC-1121B and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy
收藏DataCite Commons2025-10-17 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004461/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to gather information about the use of an investigational drug called Ramucirumab in adenocarcinomas of the stomach or gastroesophageal junction.
提供机构：
Vivli
创建时间：
2019-09-09
